Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0XM9M
|
|||
Drug Name |
Methyl-piperidine compound 1
|
|||
Synonyms |
PMID28627961-Compound-36
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Angiogenesis disorder [ICD-11: BE2Z] | Patented | [1], [2] | |
Neoplasm [ICD-11: 2A00-2F9Z; ICD-10: C76-C80] | Patented | [1], [2] | ||
Company |
ELI LILLY AND COMPANY
|
|||
Structure |
Download2D MOL |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Prostaglandin E synthase (PTGES) | Target Info | Inhibitor | [2] |
Target's Patent Info | Prostaglandin E synthase (PTGES) | Target's Patent Info | [2] | |
BioCyc | C20 prostanoid biosynthesis | |||
KEGG Pathway | Arachidonic acid metabolism | |||
Metabolic pathways | ||||
NetPath Pathway | IL1 Signaling Pathway | |||
TCR Signaling Pathway | ||||
Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
WikiPathways | Arachidonic acid metabolism | |||
Eicosanoid Synthesis |
References | Top | |||
---|---|---|---|---|
REF 1 | VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016).Expert Opin Ther Pat. 2017 Sep;27(9):987-1004. | |||
REF 2 | Microsomal prostaglandin E2 synthase-1 inhibitors: a patent review.Expert Opin Ther Pat. 2017 Sep;27(9):1047-1059. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.